EGFR and lung adenocarcinoma: In this study, we confirm the frequencies of somatic mutations in these genes in the Mexican population, with 24% for EGFR and 16% for KRAS, compared to 20% and 10%, respectively in the Carrot-Zhang recent study that included Mexican patients with lung adenocarcinoma [19].